ClearPoint Neuro
CLPT | NASDAQ
$8.30
-$0.18 (-2.12%)
At close: Nov 16, 2026, 4:00 PM ET
$8.26
-$0.04 (-0.48%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.12%
(1D)No price chart data available for 1D timeframe.
Rating
44
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #418/1021 (Top 41%)
Key Statistics
Market Data
Market Cap $266.05M
1D Range
8.12 8.48
52W Range
8.12 19.43
Valuation (TTM)
PE -6.86
PB 9.76
EV/EBITDA -10.93
Valuation (NTM)
Forward PE N/A
Forward PEG -0.17
Price Target $21.50
Cash Flow
FCF Yield -12.5%
SBC Adj. FCF Yield -15.6%
SBC Impact -25.1%
Margins
Gross Margin 61.4%
Operating Margin -70.6%
FCF Margin -73.0%
Growth (CAGR)
Revenue 3Y | 5Y 26.8% |
23.7%
Dil EPS 3Y | 5Y -28.5% |
-11.7%
FCF 3Y | 5Y -64.5% |
-16.7%
Returns
ROA -32.0%
ROE -170.2%
ROIC -31.1%
Financial Health
Net Debt
$4.66M
Current Ratio 6.76
Interest Coverage -6.49
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minima...
Sector Healthcare
Industry Medical - Devices
Employees 172
IPO Date May 22, 2012
Website www.clearpointneuro.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 28, 2026
EPS
-$0.24
Beat +23.81%
YoY:
-14.29% REV
$12.08M
Miss -1.83%
YoY:
+36.27%Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$21.50
Upside
+159.04%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CLPT